ArticleActa oncologica (Stockholm, Sweden)2025

Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study.

Charlotte Alverbratt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.